Compass Therapeutics Correlations

CMPX Stock

USD 4.99 0.18 3.48%

The current 90-days correlation between Compass Therapeutics and Fulcrum Therapeutics is 0.02 (i.e., Significant diversification). The correlation of Compass Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Compass Therapeutics Correlation With Market

Average diversification

The correlation between Compass Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Compass Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Compass Stock

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compass Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Moving together with Compass Stock

0.67	GILD	Gilead Sciences	Pair Corr
0.82	AMGN	Amgen Inc	Pair Corr
0.77	FTV	Fortive Corp	Pair Corr
0.73	CAT	Caterpillar	Pair Corr
0.74	KO	Coca Cola	Pair Corr
0.65	TRV	The Travelers Companies	Pair Corr
0.71	XOM	Exxon Mobil Corp Aggressive Push	Pair Corr
0.84	CSCO	Cisco Systems	Pair Corr
0.84	MRK	Merck Company	Pair Corr
0.62	BAC	Bank of America	Pair Corr
0.68	MCD	McDonalds	Pair Corr

Moving against Compass Stock

0.82	HD	Home Depot	Pair Corr
0.82	MSFT	Microsoft Sell-off Trend	Pair Corr
0.71	PG	Procter Gamble	Pair Corr
0.69	HPQ	HP Inc	Pair Corr
0.43	MGMA	Metro Global Media	Pair Corr
0.39	CVX	Chevron Corp	Pair Corr

Related Correlations Analysis

	FULC	FDMT	OCGN	BCYC	GOSS	LXRX	MNPR	CRVS	KALV	OMER
FULC		-0.18	-0.31	-0.18	0.81	-0.56	-0.46	0.31	0.77	0.55	FULC
FDMT	-0.18		-0.31	0.03	-0.11	0.39	0.19	0.51	-0.19	-0.26	FDMT
OCGN	-0.31	-0.31		0.79	-0.59	0.23	0.41	-0.86	-0.55	-0.47	OCGN
BCYC	-0.18	0.03	0.79		-0.46	0.35	0.46	-0.54	-0.42	-0.39	BCYC
GOSS	0.81	-0.11	-0.59	-0.46		-0.54	-0.51	0.59	0.92	0.57	GOSS
LXRX	-0.56	0.39	0.23	0.35	-0.54		0.74	0.03	-0.54	-0.61	LXRX
MNPR	-0.46	0.19	0.41	0.46	-0.51	0.74		-0.17	-0.61	-0.74	MNPR
CRVS	0.31	0.51	-0.86	-0.54	0.59	0.03	-0.17		0.52	0.31	CRVS
KALV	0.77	-0.19	-0.55	-0.42	0.92	-0.54	-0.61	0.52		0.69	KALV
OMER	0.55	-0.26	-0.47	-0.39	0.57	-0.61	-0.74	0.31	0.69		OMER
	FULC	FDMT	OCGN	BCYC	GOSS	LXRX	MNPR	CRVS	KALV	OMER

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

KALV	+ 0.92	GOSS
GOSS	+ 0.81	FULC
BCYC	+ 0.79	OCGN
KALV	+ 0.77	FULC
MNPR	+ 0.74	LXRX
OMER	+ 0.69	KALV

High negative correlations

CRVS	- 0.86	OCGN
OMER	- 0.74	MNPR
KALV	- 0.61	MNPR
OMER	- 0.61	LXRX
GOSS	- 0.59	OCGN
LXRX	- 0.56	FULC

Risk-Adjusted Indicators

There is a big difference between Compass Stock performing well and Compass Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Compass Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
FULC	4.68	0.53	0.09	(1.30)	4.76	(5.50)	11.56	(7.75)	53.70
FDMT	4.13	(0.30)	0.00	(0.03)	0.00	0.00	8.65	(7.85)	36.16
OCGN	2.99	(0.30)	0.00	(0.10)	0.00	0.00	5.41	(6.56)	14.68
BCYC	3.23	(0.20)	0.00	(0.15)	0.00	0.00	6.65	(6.20)	17.81
GOSS	4.03	0.12	0.04	0.10	4.93	(4.19)	9.59	(7.04)	31.39
LXRX	3.45	(0.29)	0.00	(0.06)	0.00	0.00	9.86	(6.49)	27.27
MNPR	3.27	(0.34)	0.00	(0.11)	0.00	0.00	5.46	(8.57)	27.74
CRVS	2.85	(0.01)	0.00	0.04	3.43	(2.99)	6.11	(5.41)	17.21
KALV	2.97	0.34	0.11	0.25	3.04	(3.37)	8.43	(5.92)	22.91
OMER	8.74	3.40	0.61	2.39	4.08	(11.41)	15.37	(8.11)	171.64

Compass Therapeutics Corporate Management

Susan Kalled	Chief Officer	Profile
MD MBA	Chief Officer	Profile
Barry JD	Chief Officer	Profile
Neil CPA	Senior Officer	Profile
Peter Moesta	Interim CMC	Profile
Anna Gifford	Communications Manager	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC